ライフサイエンスコーパス: PBMC

1 PBMC and T-cell clones (n = 570, 84% CD4(+)) from blood

2 PBMC FcepsilonRIalpha mRNA expression measured on study

3 PBMC from uveitis patients were assayed for MC5r express

4 PBMC microarray analysis detected 117 genes that were di

5 PBMC or polyclonal NK cells isolated from normal donors

6 PBMCs and pDCs isolated from children with exacerbation-

7 PBMCs from allergic subjects exhibit higher IL-5 and IL-

8 PBMCs from MS patients stimulated with a TLR-9 agonist s

9 PBMCs isolated from healthy CMV/EBV seropositive partici

10 PBMCs of IP children stimulated with heat-killed S. pneu

11 PBMCs were collected from nine participants kept in cons

12 PBMCs were incubated with lipopolysaccharide and adenosi

13 PBMCs were stimulated with an anti-CD3 antibody and IL-4

14 and a minute contamination of 0.12 +/- 0.04% PBMCs while simultaneously enabling a 20x volumetric con

15 HIV-1 DNA and 0.40 and 0.19 log10copies/10(6)PBMCs for CA HIV-1 RNA.

16 modest, i.e., 0.15 and 0.10 log10copies/10(6)PBMCs, respectively, for CA HIV-1 DNA and 0.40 and 0.19

17 unctional activity of truncated TSLP using a PBMC-based bioassay.

18 intersubject coefficients of variation after PBMC (43%) and IMC (42%) were similar.

19 Although PBMC carry many theoretical advantages for translational

20 ferences in findings between whole blood and PBMC MGIAs and should be considered when using such assa

21 .0 +/- 12.4 mL/cm(3) with BPR correction and PBMC, a 188% +/- 32% increase compared with that without

22 showed marked mitochondrial dysfunction and PBMC obtained from subjects homozygous for the TT genoty

23 Cytokine levels in serum and PBMC culture supernatants were assessed by suspension ar

24 n sarcoidosis alveolar macrophages (AMs) and PBMCs.

25 e differentiated from mouse bone marrow, and PBMCs were isolated from subjects with birch pollen alle

26 -inflammatory cytokines from murine mDCs and PBMCs from patients with birch allergy.

27 ed immunosorbent assay in T-cell subsets and PBMCs from patients with asthma and atopic dermatitis.

28 Inflamed ileal tissues and PBMCs from patients with CD had lower levels of SHIP pro

29 Pretreatment with the TRPM8 antagonist PBMC reduced cold-induced responses, and the effect was

30 sed with culture of HIV MDSC with autologous PBMCs.

31 toring signal at higher levels of background PBMCs.

32 The mean difference in VT between PBMC and IMC was -3% +/- 8%, which was insignificant (P

33 , and nested PCR for HIV RNA and DNA on bulk PBMCs and sigmoid biopsies were negative.

34 ound that lysis of articular chondrocytes by PBMC or polyclonal NK cells was potentiated by stimulati

35 yglucose and radiation treatment followed by PBMC chemotaxis determination via fluorescence microscop

36 lated production of TH2 and TH1 cytokines by PBMCs (Ps < .05).

37 ptors, and functionality of T cells in CCPs, PBMCs were isolated.

38 ormalized peripheral blood mononuclear cell (PBMC) ADA activity, improved lymphocyte numbers, and nor

39 ersity in peripheral blood mononuclear cell (PBMC) and plasma samples from 77 dengue patients.

40 standard peripheral blood mononuclear cell (PBMC) based viral outgrowth methodology and from it crea

41 hBMSC and peripheral blood mononuclear cell (PBMC) co-cultured exosomes.

42 okines in Peripheral blood mononuclear cell (PBMC) culture from CM allergic patients and nonallergic

43 on of the peripheral blood mononuclear cell (PBMC) fraction were efficiently separated and trapped at

44 estigated peripheral blood mononuclear cell (PBMC) microRNA and protein-coding gene expression data f

45 reducing peripheral blood mononuclear cell (PBMC) or lymph node proviral DNA levels.

46 -specific peripheral blood mononuclear cell (PBMC) proliferation was evident, while decreased mitogen

47 of human peripheral blood mononuclear cell (PBMC) responses to Escherichia coli was employed.

48 gated 607 peripheral blood mononuclear cell (PBMC) samples from 107 CMV-seropositive, HIV-infected me

49 (CEC) and peripheral blood mononuclear cell (PBMC) transcriptomics in patients receiving high-dose st

50 ncreas or peripheral blood mononuclear cell (PBMC), which can target the NF-kappaB1/p50 gene and inhi

51 mbers in peripheral blood mononuclear cells (PBMC) (Rho = 0.4011; P = 0.0027).

52 eased in peripheral blood mononuclear cells (PBMC) along with the number of copies of the CNV.

53 nd human peripheral blood mononuclear cells (PBMC) by MTT assay.

54 received peripheral blood mononuclear cells (PBMC) derived from allergic patients with sensitization

55 ve human peripheral blood mononuclear cells (PBMC) exposed to P. falciprum infected erythrocyte lysat

56 Peripheral blood mononuclear cells (PBMC) from 20 HDM-allergic individuals were stimulated w

57 Peripheral blood mononuclear cells (PBMC) from 20 HDM-allergic individuals were stimulated w

58 rowth in peripheral blood mononuclear cells (PBMC) from both humans and macaques was increased follow

59 ted from peripheral blood mononuclear cells (PBMC) from cancer patients produced high NO levels.

60 ction of peripheral blood mononuclear cells (PBMC) from SM or vervet AGM.

61 th human peripheral blood mononuclear cells (PBMC) in NOD/SCID mice harboring xenografts of MDA-MB-23

62 duced in peripheral blood mononuclear cells (PBMC) of AD subjects.

63 which in peripheral blood mononuclear cells (PBMC) stimulated the production of VEGF-D.

64 ences in peripheral blood mononuclear cells (PBMC), and in purified cell subsets from affected and un

65 icity in peripheral blood mononuclear cells (PBMC), good cell-permeability, and metabolic stability i

66 (WB) and peripheral blood mononuclear cells (PBMC).

67 culating peripheral blood mononuclear cells (PBMC).

68 ssion in peripheral blood mononuclear cells (PBMC).

69 on human peripheral mononuclear blood cells (PBMCs) treated with the LRRK2 inhibitor Lu AF58786 a num

70 years in peripheral blood mononuclear cells (PBMCs) among 61 perinatally HIV-1-infected youths in the

71 onses in peripheral blood mononuclear cells (PBMCs) and breast milk cells (BMCs) is increased for CD8

72 at human peripheral blood mononuclear cells (PBMCs) and cell lines expressing the risk variant IFIH1(

73 ation of peripheral blood mononuclear cells (PBMCs) and interferon gamma (IFN-gamma) production were

74 XCR4) on peripheral blood mononuclear cells (PBMCs) and macrophages ex vivo as a potential mechanism

75 tions of peripheral blood mononuclear cells (PBMCs) and monocytes obtained during hyperinsulinemic-eu

76 rtion of peripheral blood mononuclear cells (PBMCs) and of CSF white blood cells (WBCs) that were act

77 Peripheral blood mononuclear cells (PBMCs) and plasma were collected at and 2 time points af

78 on bulk peripheral blood mononuclear cells (PBMCs) and sigmoid biopsies after seroconversion.

79 lls from peripheral blood mononuclear cells (PBMCs) and that activation can be inhibited by ibrutinib

80 om human peripheral blood mononuclear cells (PBMCs) by intracellular staining and dual-secretion assa

81 om human peripheral blood mononuclear cells (PBMCs) by intracellular staining and dual-secretion assa

82 ollected peripheral blood mononuclear cells (PBMCs) by leukapheresis from a 55-year-old man with chro

83 y, using peripheral blood mononuclear cells (PBMCs) collected at the acute visit (2 to 3 days after i

84 rrays on peripheral blood mononuclear cells (PBMCs) from 18 early-onset SZ cases and 12 controls.

85 ffect in peripheral blood mononuclear cells (PBMCs) from 30 premutation carriers with either a rebala

86 ys using peripheral blood mononuclear cells (PBMCs) from 5 viremic patients and 20 patients receiving

87 ENV-2 on peripheral blood mononuclear cells (PBMCs) from children in Thailand with acute primary or s

88 Peripheral blood mononuclear cells (PBMCs) from donors positive for IgE towards ragweed extr

89 screened peripheral blood mononuclear cells (PBMCs) from donors vaccinated with a tetravalent DLAV va

90 d HIV in peripheral blood mononuclear cells (PBMCs) from HIV-infected individuals on suppressive anti

91 Peripheral blood mononuclear cells (PBMCs) from infection-prone (IP) and non-IP (NIP) childr

92 ther, in peripheral blood mononuclear cells (PBMCs) from patients with cutaneous leishmaniasis, CpG t

93 xposure, peripheral blood mononuclear cells (PBMCs) from patients with SVR upregulated TRAIL, as well

94 isolated peripheral blood mononuclear cells (PBMCs) from peanut-allergic (PA) and nonallergic subject

95 tion and peripheral blood mononuclear cells (PBMCs) from treatment-naive subjects with CD or without

96 tro with peripheral blood mononuclear cells (PBMCs) in the presence of the glycolysis inhibitor 2-deo

97 ivity of peripheral blood mononuclear cells (PBMCs) in vitro and from Nicaraguan Zika patients and sh

98 Peripheral blood mononuclear cells (PBMCs) obtained from allergic individuals and non-allerg

99 asma and peripheral blood mononuclear cells (PBMCs) of 2146 patients who had blood specimens sent to

100 tions in peripheral blood mononuclear cells (PBMCs) of 686 women with primary OC (n = 412) or relapse

101 pooling peripheral blood mononuclear cells (PBMCs) of six select HIV-1 chronically infected Indian d

102 es human peripheral blood mononuclear cells (PBMCs) to lyse leukemic cell lines and primary acute mye

103 hours in peripheral blood mononuclear cells (PBMCs) using the Infinium Methylation 450K array.

104 Peripheral blood mononuclear cells (PBMCs) were also isolated.

105 XCR3) in peripheral blood mononuclear cells (PBMCs) were assayed.

106 Human peripheral blood mononuclear cells (PBMCs) were isolated from blood of healthy donors.

107 V DNA in peripheral blood mononuclear cells (PBMCs) were longitudinally monitored before and after an

108 mbers of peripheral blood mononuclear cells (PBMCs) were obtained longitudinally from both participan

109 s, human peripheral blood mononuclear cells (PBMCs), and mouse splenocytes incubated without or with

110 m feline peripheral blood mononuclear cells (PBMCs), and used available immunoglobulin sequences and

111 CD62E(+) peripheral blood mononuclear cells (PBMCs), muscle mitochondrial capacity, and maximal oxyge

112 of human peripheral blood mononuclear cells (PBMCs).

113 CTLs) in peripheral blood mononuclear cells (PBMCs).

114 ation in peripheral blood mononuclear cells (PBMCs).

115 nd human peripheral blood mononuclear cells (PBMCs).

116 V RNA in peripheral blood mononuclear cells (PBMCs; n = 72), seminal plasma (n = 20), cerebrospinal f

117 m proviral HIV-1 DNA detected in circulating PBMCs before transplantation.

118 This study used longitudinally collected PBMC samples from a population-based cohort of challenge

119 the population-based metabolite correction (PBMC) and the individual metabolite correction (IMC) cur

120 Ag-reactive plasmablasts from cryopreserved PBMC obtained from volunteers vaccinated with a recombin

121 induced more cytokine production in cultured PBMCs than did polynephron membranes.

122 Addition of monoclonal IgE to cultured PBMCs significantly (P = .04) increased CD23 expression

123 -regulated reactive oxygen species-dependent PBMC chemotaxis to HNSCC spheroids.

124 Monocyte-depleted PBMCs were treated with phytohemagglutinin for 72 hours

125 THP1, Jurkat and primary MS patient-derived PBMC firm adhesion.

126 06(+) macrophages in human PBMCs, especially PBMCs that express low-affinity FcgammaRIIIa.

127 For PBMC specimens, the sensitivity of the Aptima assay in t

128 Contrary to the hypothesis formulated, PBMCs from infected patients obtained at the time of inf

129 ions in porcine blood, DC were enriched from PBMC by CD14 depletion and CD172a enrichment then staine

130 ines (TCL) and clones (TCC) established from PBMC of birch pollen-allergic patients with carrot aller

131 we were able to recover infectious HIV from PBMC with heat shock.

132 differentiated in the presence of IL-10 from PBMCs of patients with PA and HC subjects pulsed with th

133 Total RNA was isolated from PBMCs of five children with atopic dermatitis.

134 coupled with corresponding measurements from PBMCs and plasma from the same donors.

135 We recovered mRNA from PBMCs from two cats, cloned and sequenced the variable a

136 telomere repeat amplification protocol from PBMCs and enriched lymphocyte cultures.

137 We exposed purified NK cells and full PBMCs from healthy donors to PLT-Ecto.

138 Furthermore, PBMCs isolated from the ENL patients secreted higher lev

139 )(NSG) mice were reconstituted with human (h)PBMCs immediately after both carotid wire and femoral cu

140 271074 suppressed IL-17A production in human PBMC from rheumatoid arthritis patients.

141 gulated a range of CC-induced genes in human PBMC.

142 Transfection of human PBMC's with TTSuV1 genomic DNA resulted in productive vi

143 stimulated TNF-alpha production in the human PBMC cells but only weakly affecting the normal PBMC cel

144 with (E1)-3s or (14)-3s combined with human PBMC in 3D spheroids generated from target cell lines to

145 Human PBMCs were genotyped for FCGR3A158 (the FcgammaRIIIa-158

146 of E-selectin ligand expression among human PBMCs, indicating that circulating monocytes are special

147 endritic cells, mouse neutrophils, and human PBMCs.

148 t, we demonstrate that T cell-depleted human PBMCs exposed to UV-HSV-1 provide a survival benefit in

149 te lymphoid cell subsets purified from human PBMCs and mouse lung ILC2s.

150 tometry in T and B cells isolated from human PBMCs obtained from healthy donors that had been stimula

151 damage by gamma-H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCR

152 ring with IL-17A receptor signaling in human PBMCs attenuated the expression of numerous inflammatory

153 t strong protective immune response in human PBMCs from HVL, similar to the wild type parasite infect

154 anel of 13 reported anti-HIV miRNAs in human PBMCs from long term non progressors (LTNPs), regular pr

155 -sensitive nanoparticle (NP; PC7A), in human PBMCs induces potent and long-acting antiretroviral resp

156 ross-linking with its ligand ICAM-1 in human PBMCs or CD4(+) T cells promotes Th1 polarization by upr

157 Thr73 as a LRRK2 inhibition marker in human PBMCs strongly support inclusion of assays quantifying R

158 R1 tetramers that detect MAIT cells in human PBMCs, and stimulates cytokine expression (IFNgamma, TNF

159 In human PBMCs, anti-TNF increased the number of CD206(+) macroph

160 development of CD206(+) macrophages in human PBMCs, especially PBMCs that express low-affinity Fcgamm

161 r of TCR and BCR specific signaling in human PBMCs.

162 phoproliferative responses in infected human PBMCs were diminished when compared to the controls.

163 tectable in the culture supernatant of human PBMCs and murine spleen cells stimulated with anti-CD3 a

164 In addition, treatment of human PBMCs or mouse splenocytes containing destabilizing STAT

165 ic, and we observed similar effects on human PBMCs.

166 rotein E-selectin ligands expressed on human PBMCs.

167 on in cultures of mouse splenocytes or human PBMCs was elevated upon polyclonal T cell activation, an

168 In addition, in non-stimulated human PBMCs acute inhibition of LRRK2 with two distinct LRRK2

169 ion was validated in immune stimulated human PBMCs using two distinct LRRK2 inhibitors.

170 Although sCD83 binds to human PBMCs, the specific molecules that bind sCD83 have not b

171 ture system, which uses unfractionated human PBMCs as the starting material.

172 duced IFN target gene expression using human PBMCs.

173 -2rcgamma(-/-) mice reconstituted with human PBMCs (NSG-huPBMC).

174 ver mechanisms underlying the alterations in PBMC transcriptomes, we profiled the expression of micro

175 analysis did not demonstrate differences in PBMC transcriptome between the two groups on the single-

176 The presence of intermittent CMV DNA in PBMC during ART was significantly associated with slower

177 ese results suggest that pCREB expression in PBMC may be indicative of its expression in the brain, a

178 UK/Asian adults and, to a lesser extent, in PBMC from South African infants.

179 s of the specific IL-27 receptor (IL27RA) in PBMC correlated directly with both plasma viral load (Rh

180 come period and correlated with increases in PBMC IFN-alpha responses.

181 In addition, pCREB levels in PBMC positively correlated with pCREB expression in the

182 that nitration of the STAT1-Tyr701 occurs in PBMC derived from both pancreatic cancer and melanoma pa

183 urthermore, the significant perturbations in PBMC transcriptome may help determine the beneficial eff

184 ndary to dysregulation of IL-5 production in PBMC (and their component subsets).

185 to assess CEC and transcriptomic profile in PBMC.

186 sulted in decreased inflammatory response in PBMC but increased activation of gut lymphocytes.

187 of viral load and proviral reservoir size in PBMC.IMPORTANCE The detailed knowledge of immune mechani

188 he motif ASS[LF]R[SW][TD][DT][TE][QA][YF] in PBMC repertoires.

189 In PBMCs of allergic rhinitis participants, 42 sites showed

190 In PBMCs, SSRI treatment decreased expression of CD4 (p = .

191 An increased expression of miR-323-3p in PBMCs from patients with asthma and reverse correlation

192 rrelation between levels of SHIP activity in PBMCs and induction of IL1beta production by lipopolysac

193 Intracellular BPA in PBMCs increased after chronic hemodialysis with polysulf

194 We profiled antigen-responsive cells in PBMCs by flow cytometry, and examined cells in whole blo

195 T cells and IL-17 secreting CD4(+) cells in PBMCs from HVL cases with no increase in IL-10 secreting

196 of CXCR3 expression in CD3-positive cells in PBMCs was inversely correlated with serum CXCL10 levels

197 rcentage of activated CD4(+)CD25(+) cells in PBMCs.

198 production of pro-inflammatory cytokines in PBMCs.

199 MND-ADA vector was persistently detected in PBMCs (vector copy number [VCN] = 0.1-2.6) and granulocy

200 Viral RNA was detected in PBMCs from all patients, but in serum from only a subset

201 ed in plasma in 99% of cases but detected in PBMCs in only 54%.

202 signatures of B and plasma cells detected in PBMCs were highly correlated with antibody titers precha

203 ty for EBV(+)disease as compared with EBV in PBMCs.

204 , inducible NO synthetase) were evaluated in PBMCs.

205 nd cross-reactive B cells were identified in PBMCs from all subjects.

206 markers of demargination and inflammation in PBMCs.

207 et gene activation were also investigated in PBMCs.

208 significantly reduced proviral DNA levels in PBMCs after 2 weeks and in lymph nodes after 10 weeks.

209 associated with ANKRD55 transcript levels in PBMCs and CD4(+) T cells and, thus, coincides with a cis

210 pe I IFN signaling and requires monocytes in PBMCs.

211 equency of somatic mosaic PPM1D mutations in PBMCs was significantly associated with prior chemothera

212 e association of somatic mosaic mutations in PBMCs with cancer risk.

213 regulatory B cells (Bregs) were observed in PBMCs of invasive carcinoma of breast (IBCa) patients co

214 (+)disease (n = 402), it was present only in PBMCs in 69% of cases.

215 ed that ET-1-producing cells emerged only in PBMCs stimulated with anti-CD3 antibody.

216 ere assessed by means of quantitative PCR in PBMCs from 80 patients with grass pollen allergy before

217 Reduced Th17 responses to S. pneumoniae in PBMCs of IP children can be rescued by addition of Th17-

218 en miR-323-3p levels and IL-22 production in PBMCs cultured in T-cell growth conditions was observed.

219 IIIa; numbers of these cells were reduced in PBMCs with the low-affinity FcgammaRIIIa-158F genotype.

220 vealed a novel and robust aging signature in PBMCs, with simultaneous systematic chromatin closing at

221 ylation of the transcription factor STAT1 in PBMCs from patients with SVR.

222 LFA-1 stimulation in PBMCs, CD4(+) T cells, or the T cell line HuT78 activate

223 pressures as well as replicative success in PBMCs and potentially other replication sites.

224 re less likely to have EBV in plasma than in PBMCs in the absence of EBV(+)disease.

225 matin accessibility and the transcriptome in PBMCs and purified monocytes, B cells, and T cells.

226 polysaccharide and adenosine triphosphate in PBMCs.

227 DC) markers, such as C1Q, are upregulated in PBMCs of patients with grass pollen allergy exhibiting c

228 increased rhinovirus- and influenza-induced PBMC and rhinovirus-induced pDC IFN-alpha responses in t

229 60% NK cell mediated lysis of HIV-1 infected PBMCs in a physiologically relevant ADCC model, highligh

230 mes suppressed immune reaction by inhibiting PBMC proliferation and enhancing regulatory T cell (Treg

231 Vimentin supplementation of IPF PBMC cultures also resulted in HLA-DR-dependent producti

232 significantly increased in freshly isolated PBMC from affected family members, this was not accompan

233 tracellular heme oxygenase 1 (HO-1) isolated PBMCs were used.

234 From ex vivo-isolated PBMCs, we found high expression of CD200R on Th2 and ILC

235 We show that memory PBMC expansion with either HSV or VZV enriches for CD4 T

236 val [CI], -.36 to -.13) log10 copies/million PBMCs per year and was faster with early VS by age 1 yea

237 (95% CI, -.06 to -.03) log10 copies/million PBMCs per year and was no longer significantly different

238 age 1 (-0.50 and -0.15 log10 copies/million PBMCs per year, respectively).

239 s (monocyte-derived dendritic cells [moDCs], PBMCs [peripheral blood mononuclear cells] and epithelia

240 Peripheral blood monocyte (PBMC) expression of mRNA for TLRs 2, 3, 4, 7, and 9 was

241 In addition, exposure of human and mouse PBMCs to SEB in vitro showed a significant reduction in

242 C cells but only weakly affecting the normal PBMC cell proliferation.

243 However, coculture of normal PBMCs with Env-expressing cells resulted in selective CD

244 Testing of longitudinally obtained PBMC samples showed little variation for either viremic

245 Culture of PBMC experiments yielded that IDO mRNA expression was no

246 low) cells proliferating upon stimulation of PBMC with Dau c 1 or Bet v 1.

247 Coculture of PBMCs from healthy subjects with HCV-infected hepatoma c

248 In clinical isolates of PBMCs from lymphangioleiomyomatosis patients, VEGF-D exp

249 ed maturation of moDCsc and proliferation of PBMCs.

250 Median proportion of PBMCs that were activated monocytes (16.6 vs. 5.3), and

251 lls was measured, as well as the response of PBMCs to stimulation with TLR ligands.

252 In vitro mitogenic stimulation of PBMCs resulted in upregulation of IA markers but failed

253 this study, we compared the transcriptome of PBMCs from a GBS patient and her healthy twin to discove

254 nd that sample heterogeneity makes RNASeq on PBMC unsuitable as a first-step method for screening bio

255 decreased CD4, CCR5, and CXCR4 expression on PBMCs and macrophages ex vivo.

256 FACS analysis was performed on PBMCs and intrahepatic lymphocytes.

257 Conjugates were added to RAW 264.7 or PBMC cells in a range of 1 mug/ml to 100 mug/ml for 24 h

258 gly, ex vivo treatment of sarcoidosis AMs or PBMCs with IRAK1/4 inhibitor led to a significant increa

259 patients (25%) had EBV detected in plasma or PBMCs.

260 inhibit HIV-1 replication in HIV(+) patient PBMCs after ex vivo reactivation.

261 We found that ethanol primed PBMCs for LPS-induced inflammatory responses.

262 (UV-HSV-1) is equally effective in promoting PBMC cytolysis of leukemic cells and is 1000- to 10 000-

263 received intraperitoneally allergen-reactive PBMC from birch pollen-allergic patients together with b

264 The ALS twin's PBMCs spontaneously produced IL-6 and TNF-alpha, whereas

265 y inhibited SIVagmSab replication in sabaeus PBMC and had a greater impact than did the CCR5 blocker

266 Methylation studies in saliva, PBMCs, and human bronchial epithelial cells were done to

267 In sequential PBMC samples harvested from 13 patients with OC near dia

268 AG-3 pathways partially restored OM-specific PBMC proliferation and IFN-gamma production at 5 wpi.

269 levels in supernatants from both stimulated PBMC and ILC2 cultures.

270 Drug-stimulated PBMCs or coculture systems were used to detect memory T

271 IL-10 mRNA was higher in IFX-stimulated PBMCs from treated patients compared with untreated pati

272 chemokine levels were measured in stimulated PBMCs and plasma.

273 ted CD154(+) T cells, IFX peptide-stimulated PBMCs, and IFX-specific T cell clones.

274 gated the secondary effect of SAg-stimulated PBMCs on human dermal fibroblasts as judged by C/EBP del

275 Mechanistically, UV-HSV-1 stimulates PBMC cytolysis of leukemic cells, partly via Toll-like r

276 but in serum from only a subset, suggesting PBMCs may be a reservoir for ZIKV.

277 Our study suggests that PBMC gene expression is useful in diagnosis of sarcoidos

278 The PBMC HO-1 messenger RNA also increased: HA 2.73-fold ver

279 the stimulation by M. leprae antigens in the PBMC (peripheral blood mononuclear cells) of 69 healthy

280 ytes, B lymphocytes and monocytes within the PBMC subpopulations was evaluated by immunostaining and

281 different in their expression levels in the PBMCs of PTSD patients.

282 the viruses identified pre-transplant in the PBMCs.

283 hen hypo-fucosylated adalimumab was added to PBMCs, a larger number of CD206(+) macrophages formed an

284 on IgE production by IL-4/anti-CD40-treated PBMCs from allergic patients were studied in vitro.

285 of HIV RNA decayed as background uninfected PBMC counts increased; proteinase K treatment demonstrat

286 The HA upregulated PBMC HO-1 protein more than placebo at 24 hours: HA 11.1

287 we performed a transcriptome analysis using PBMCs isolated on day 7 post-modified vaccinia Ankara va

288 n vitro and ex vivo human cell assays, using PBMCs from type 1 diabetes patients, had significant imp

289 Interestingly, using PBMCs, the subject infected with the virus encoding the

290 0.0001 to 0.037) for assays performed using PBMCs from different sources (phlebotomy versus leukaphe

291 2 and Mal d 4) were measured in vitro using PBMCs from 26 Spanish grass-allergic donors IgE-sensitiz

292 IFN-gamma responses were observed in ex vivo PBMC stimulated with E2 and NS3 proteins in both vaccina

293 Ex vivo, PBMCs and monocytes displayed a more robust cytokine res

294 neously produced IL-6 and TNF-alpha, whereas PBMCs of the healthy twin produced these cytokines only

295 ication of resting CD4(+) T cells from whole PBMC is expedited and achieved in 3 hours, less than hal

296 BPR correction (P = 2.3e-04) as well as with PBMC (P = 1.6e-05).

297 production upon restimulation compared with PBMCs from controls, a difference that disappeared after

298 rs is increased in breast milk compared with PBMCs.

299 t of patients and tested for comparison with PBMCs.

300 n in monocyte/macrophage cell numbers within PBMCs in a dose-dependent manner.